Mingfeng Guan
Shanghai Institute of Organic Chemistry(CN)University of Chinese Academy of Sciences(CN)
Publications by Year
Research Areas
Asthma and respiratory diseases, Immune Response and Inflammation, CRISPR and Genetic Engineering, NF-κB Signaling Pathways, Alzheimer's disease research and treatments
Most-Cited Works
- → Phase Separation of Disease-Associated SHP2 Mutants Underlies MAPK Hyperactivation(2020)263 cited
- → Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice(2012)178 cited
- → Licochalcone A Inhibits Lipopolysaccharide-Induced Inflammatory Response in Vitro and in Vivo(2012)118 cited
- → Effects of a Natural Prolyl Oligopeptidase Inhibitor, Rosmarinic Acid, on Lipopolysaccharide-Induced Acute Lung Injury in Mice(2012)113 cited
- → Effects of an anthraquinone derivative from Rheum officinale Baill, emodin, on airway responses in a murine model of asthma(2012)59 cited
- → Geniposide inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma(2013)51 cited
- → Protocatechuic acid suppresses ovalbumin-induced airway inflammation in a mouse allergic asthma model(2013)49 cited
- → Long noncoding RNA BS-DRL1 modulates the DNA damage response and genome stability by interacting with HMGB1 in neurons(2021)49 cited
- → Protocatechuic Acid Attenuates Lipolysaccharide-Induced Acute Lung Injury(2012)47 cited
- → Attenuation of allergic airway inflammation in a murine model of asthma by Licochalcone A(2013)40 cited